Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Rationally evolving MCP-1/CCL2 into a decoy protein with potent anti-inflammatory activity in vivo.

The Journal of biological chemistry - 19 Mar 2010

Piccinini Anna Maria, Knebl Kerstin, Rek Angelika, Wildner Gerhild, Diedrichs-Möhring Maria, Kungl Andreas J

Abstract excerpt

Leukocyte recruitment from the blood into injured tissues during inflammatory diseases is the result of sequential events involving chemokines binding to their GPC receptors as well as to their glycosaminoglycan (GAG) co-receptors. The induction and the crucial role of MCP-1/CCL2 in the course of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-Inflammatory Agents
Share to Chemokine CCL2
Share to Chemokines

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Chemotaxis

Share to Leukocytes

Share to Monocytes

Share to Spectrometry, Fluorescence

Share to Surface Plasmon Resonance

Source

Open in PubMed Open full text

Identifiers

PMID: 20097750
DOI: 10.1074/jbc.M109.043299
PMCID: PMC2838300

Genes

CCL2
CCR2

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-20097750-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Rationally evolving MCP-1/CCL2 into a decoy protein with potent anti-inflammatory activity in vivo.PMID 20097750Read ↗

Developing chemokine mutants with improved proteoglycan affinity and knocked-out GPCR activity as anti-inflammatory recombinant drugs.Semantic proximity Read ↗

Monocyte Chemoattractant Protein‐1 (CCL2) in Inflammatory Disease and Adaptive Immunity: Therapeutic Opportunities and ControversiesSemantic proximity Read ↗

Identification of the glycosaminoglycan binding site of the CC chemokine, MCP-1: implications for structure and function in vivo.Semantic proximity Read ↗

Engineering the glycosaminoglycan-binding affinity, kinetics and oligomerization behavior of RANTES: a tool for generating chemokine-based glycosaminoglycan antagonists.Semantic proximity Read ↗

Multiple glycosaminoglycan-binding epitopes of monocyte chemoattractant protein-3/CCL7 enable it to function as a non-oligomerizing chemokine.Semantic proximity Read ↗

The CCR2 receptor as a therapeutic targetSemantic proximity Read ↗

Monocyte chemoattractant protein-1 (MCP-1): an overview.Semantic proximity Read ↗

Characterization of the chemokine CXCL11-heparin interaction suggests two different affinities for glycosaminoglycans.Semantic proximity Read ↗

C-terminal truncation of CXCL10 attenuates inflammatory activity but retains angiostatic propertiesSemantic proximity Read ↗

The molecular structure and role of CCL2 (MCP‐1) and C‐C chemokine receptor CCR2 in skeletal biology and diseasesSemantic proximity Read ↗

Interference with heparin binding and oligomerization creates a novel anti-inflammatory strategy targeting the chemokine system.Semantic proximity Read ↗

CCR1- and CCR5-mediated inactivation of leukocytes by a nonglycosaminoglycan (non-GAG)-binding variant of n-nonanoyl-CCL14 (NNY-CCL14).Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.